Abstract
Recent result of clinical trial on carcinoma of stomach demonstrate an advantage to adjuvant postoperative chemo-radiotherapy witch is now used more commonly for gastric cancer. However remain some doubt for toxicity as for the optimal chemotherapy regimen as for the optimal method of radiation delivery. To increase the biological effectiveness and, at same time, to reduce toxicity of conventional radiotherapy we tested many alternative fractionation schemes of dose radiation, using a biological equivalent Histogram Dose Volume (DVH) for prior analysis and as tool for the assessment and choice of fractionation dose biologically more effective.
| Original language | English |
|---|---|
| Title of host publication | IFMBE Proceedings |
| Pages | 223-226 |
| Number of pages | 4 |
| Volume | 25 |
| Edition | 3 |
| DOIs | |
| Publication status | Published - 2009 |
| Event | World Congress on Medical Physics and Biomedical Engineering: Radiation Protection and Dosimetry, Biological Effects of Radiation - Munich, Germany Duration: Sep 7 2009 → Sep 12 2009 |
Other
| Other | World Congress on Medical Physics and Biomedical Engineering: Radiation Protection and Dosimetry, Biological Effects of Radiation |
|---|---|
| Country | Germany |
| City | Munich |
| Period | 9/7/09 → 9/12/09 |
Fingerprint
Keywords
- Biological equivalent dose
- Chemo-radiotherapy
- Dose volume histogram
- Fractionation
- Tolerance dose
ASJC Scopus subject areas
- Biomedical Engineering
- Bioengineering
Cite this
Accelerated hypo-fractionation by biological equivalent DVH for patients affected by gastric carcinoma in postoperative concomitant radiochemotherapy. / Pedicini, P.; Mazziotta, M.; Clemente, S.; Cozzolino, M.; Caporaso, L.; Sanpaolo, P.; Barbieri, V.; Lapadula, L.; Castaldo, G.; Fusco, V.
IFMBE Proceedings. Vol. 25 3. ed. 2009. p. 223-226.Research output: Chapter in Book/Report/Conference proceeding › Conference contribution
}
TY - GEN
T1 - Accelerated hypo-fractionation by biological equivalent DVH for patients affected by gastric carcinoma in postoperative concomitant radiochemotherapy
AU - Pedicini, P.
AU - Mazziotta, M.
AU - Clemente, S.
AU - Cozzolino, M.
AU - Caporaso, L.
AU - Sanpaolo, P.
AU - Barbieri, V.
AU - Lapadula, L.
AU - Castaldo, G.
AU - Fusco, V.
PY - 2009
Y1 - 2009
N2 - Recent result of clinical trial on carcinoma of stomach demonstrate an advantage to adjuvant postoperative chemo-radiotherapy witch is now used more commonly for gastric cancer. However remain some doubt for toxicity as for the optimal chemotherapy regimen as for the optimal method of radiation delivery. To increase the biological effectiveness and, at same time, to reduce toxicity of conventional radiotherapy we tested many alternative fractionation schemes of dose radiation, using a biological equivalent Histogram Dose Volume (DVH) for prior analysis and as tool for the assessment and choice of fractionation dose biologically more effective.
AB - Recent result of clinical trial on carcinoma of stomach demonstrate an advantage to adjuvant postoperative chemo-radiotherapy witch is now used more commonly for gastric cancer. However remain some doubt for toxicity as for the optimal chemotherapy regimen as for the optimal method of radiation delivery. To increase the biological effectiveness and, at same time, to reduce toxicity of conventional radiotherapy we tested many alternative fractionation schemes of dose radiation, using a biological equivalent Histogram Dose Volume (DVH) for prior analysis and as tool for the assessment and choice of fractionation dose biologically more effective.
KW - Biological equivalent dose
KW - Chemo-radiotherapy
KW - Dose volume histogram
KW - Fractionation
KW - Tolerance dose
UR - http://www.scopus.com/inward/record.url?scp=77950170683&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77950170683&partnerID=8YFLogxK
U2 - 10.1007/978-3-642-03902-7-63
DO - 10.1007/978-3-642-03902-7-63
M3 - Conference contribution
AN - SCOPUS:77950170683
SN - 9783642039010
VL - 25
SP - 223
EP - 226
BT - IFMBE Proceedings
ER -